LIFE: Lifecare Newsletter July

Bergen, Norway 4 June 2022 

Lifecare achieved the two major milestones for 1H2022 in June, the clinical
study announced 23 June has started and Lifecare continue to strengthen the
organization. Read more in the Lifecare July newsletter:
https://lifecare.no/news/information-from-lifecare-july-2022/ 

This is Lifecare 
Lifecare is a Bergen-based technology company developing a miniaturized
implantable long-term sensor for correct and continuous monitoring of blood
sugar in people with diabetes. The Company's patented technology also has the
potential for use in various biomarkers. Lifecare AS is listed on Euronext
Growth (LIFE). 

Further information Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no,
+47 40 05 90 40 

This stock exchange announcement was published by Joacim Holter, CEO at Lifecare
AS, on 04.07.22 at 08:59 CET.